NCT06180460 2025-10-08
CALM: Managing Distress in Malignant Brain Cancer
Virginia Commonwealth University
Phase NA Completed
Clinical Trials
5 trialsNCT03843593 2023-01-04
A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery
Memorial Sloan Kettering Cancer Center
Completed
NCT02094872 2020-01-02
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
Yale University
Phase 2 Completed
NCT00132704 2014-07-24
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Memorial Sloan Kettering Cancer Center
Completed
NCT00827177 2014-01-24
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed